Drug Shortage Report for TIMOPTIC-XE
Report ID | 224103 |
Drug Identification Number | 02171899 |
Brand name | TIMOPTIC-XE |
Common or Proper name | timolol maleate |
Company Name | ELVIUM LIFE SCIENCES |
Market Status | MARKETED |
Active Ingredient(s) | TIMOLOL |
Strength(s) | 0.5% |
Dosage form(s) | SOLUTION (EXTENDED RELEASE) |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | 5ml |
ATC code | S01ED |
ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2024-04-02 |
Actual start date | 2024-04-02 |
Estimated end date | 2024-04-19 |
Actual end date | 2024-04-16 |
Shortage status | Resolved |
Updated date | 2024-04-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2024-04-17 | English | Compare |
v5 | 2024-04-16 | French | Compare |
v4 | 2024-04-16 | English | Compare |
v3 | 2024-04-03 | English | Compare |
v2 | 2024-04-02 | French | Compare |
v1 | 2024-04-02 | English | Compare |
Showing 1 to 6 of 6